Roche Holding AG

RHO5

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,567.0012.10-0.14%
CAC 407,213.3214.870.21%
DAX 4019,146.17141.390.74%
Dow JONES (US)43,792.38383.910.88%
FTSE 1008,149.2764.200.79%
HKSE19,601.11103.90-0.53%
NASDAQ18,930.8035.34-0.19%
Nikkei 22538,026.17326.17-0.85%
NZX 50 Index12,765.2428.180.22%
S&P 5005,936.5719.460.33%
S&P/ASX 2008,323.003.30-0.04%
SSE Composite Index3,370.402.410.07%

Market Movers